Application of Tc-99m-tetrofosmin as a tumor imaging agent: Comparison with Tl-201
- 1 June 1996
- journal article
- research article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 10 (2) , 271-274
- https://doi.org/10.1007/bf03165405
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Technetium-99m-tetrofosmin uptake in malignant lung tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography.1994
- Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.1993
- Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison.1993
- Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.1993
- Thallium scintigraphy in the evaluation of mass abnormalities of the breast.1993
- Clinical Experience with Tc-99m MIBI Imaging in Patients with Malignant Tumors Preliminary Results and Comparison with TI-201Clinical Nuclear Medicine, 1992